Report Overview
Interventional Cardiology Market Size:
The Interventional Cardiology Market is projected to expand from USD 26.096 billion in 2025 to USD 34.742 billion in 2030, registering a 5.89% compound annual growth rate (CAGR).
Interventional cardiology is a minimally invasive procedure that utilizes catheters to repair damaged or weakened vessels, narrowed arteries, or other affected parts of the heart structure. Catheters are medical devices consisting of thin tubes that can be inserted into the body to serve a broad range of functions. Interventional cardiology also helps to avoid surgery with treatments like angioplasty and valve repair or replacement. The interventional cardiology market is expected to show robust during the forecast period owing to the rising adoption of minimally invasive procedures and rising incidences of cardiovascular diseases. As per data by WHO, cardiovascular diseases are the leading cause of death globally with an estimated 17.9 million people dying of CVDs in 2016. Technological advancements in interventional cardiology devices will also boost the market for interventional cardiology during the forecast period. However, stringent regulatory requirements for the approval of interventional cardiology devices might restrain the growth of the interventional cardiology market during the given time frame.
Interventional Cardiology Market Drivers:
Interventional Cardiology Market Restraints:
- Regulations regarding approval of interventional cardiology devices.
- High cost of interventional cardiology procedures in developing and underdeveloped economies.
The major players profiled in the global interventional cardiology market include Medtronic[1], Stryker, Abbott, B. Braun Melsungen AG, Boston Scientific Corporation, Cordis (A Cardinal Health Company), Edwards Lifesciences Corporation, GE Healthcare, Biosensors International Group, Ltd., and Biotronik, Inc. among others.
Segmentation
- By Device Type
- Stents
- Drug-Eluting Stents (DES)
- Bare-Metal Stents (BMS)
- Bioabsorbable Stents
- Catheters
- Diagnostic Catheters
- Guiding Catheters
- Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
- Plain Old Balloon Angioplasty (POBA) Balloons
- Cutting/Scoring Balloons
- Drug-Coated Balloons (DCB)
- Atherectomy Devices
- Plaque Modification Devices
- Guidewires
- Embolic Protection Devices
- Others
- Stents
- By Application
- Coronary Artery Disease
- Heart Valve Disease
- Transcatheter Aortic Valve Replacement (TAVR)
- Transcatheter Mitral Valve Repair/Replacement (TMVR)
- Peripheral Vascular Disease
- Structural Heart Disease
- Atrial Septal Defect (ASD) Closure
- Patent Foramen Ovale (PFO) Closure
- Left Atrial Appendage (LAA) Closure
- Congenital Heart Defects
- By End-User
- Hospitals and Clinics
- Ambulatory Surgery Centers (ASCs)
- Specialty Cardiac Centers
- By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- United Kingdom
- Germany
- France
- Spain
- Others
- Middle East and Africa
- Saudi Arabia
- UAE
- Others
- Asia Pacific
- China
- Japan
- India
- South Korea
- Taiwan
- Others
- North America
Market Segmentation
By Device Type
By Application
By End-user
By Geography
Table of Contents
1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. INTERVENTIONAL CARDIOLOGY MARKET BY DEVICE TYPE
5.1. Introduction
5.2. Stents
5.2.1. Drug-Eluting Stents (DES)
5.2.2. Bare-Metal Stents (BMS)
5.2.3. Bioabsorbable Stents
5.3. Catheters
5.3.1. Diagnostic Catheters
5.3.2. Guiding Catheters
5.4. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
5.4.1. Plain Old Balloon Angioplasty (POBA) Balloons
5.4.2. Cutting/Scoring Balloons
5.4.3. Drug-Coated Balloons (DCB)
5.5. Atherectomy Devices
5.6. Plaque Modification Devices
5.7. Guidewires
5.8. Embolic Protection Devices
5.9. Others
6. INTERVENTIONAL CARDIOLOGY MARKET BY APPLICATION
6.1. Introduction
6.2. Coronary Artery Disease
6.3. Heart Valve Disease
6.3.1. Transcatheter Aortic Valve Replacement (TAVR)
6.3.2. Transcatheter Mitral Valve Repair/Replacement (TMVR)
6.4. Peripheral Vascular Disease
6.5. Structural Heart Disease
6.5.1. Atrial Septal Defect (ASD) Closure
6.5.2. Patent Foramen Ovale (PFO) Closure
6.5.3. Left Atrial Appendage (LAA) Closure
6.6. Congenital Heart Defects
7. INTERVENTIONAL CARDIOLOGY MARKET BY END-USER
7.1. Introduction
7.2. Hospitals and Clinics
7.3. Ambulatory Surgery Centers (ASCs)
7.4. Specialty Cardiac Centers
8. INTERVENTIONAL CARDIOLOGY MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Device Type
8.2.2. By Application
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. USA
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Device Type
8.3.2. By Application
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Device Type
8.4.2. By Application
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. United Kingdom
8.4.4.2. Germany
8.4.4.3. France
8.4.4.4. Spain
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Product Type
8.5.2. By Application
8.5.3. By Country
8.5.3.1. Saudi Arabia
8.5.3.2. UAE
8.5.3.3. Others
8.6. Asia Pacific
8.6.1. By Device Type
8.6.2. By Application
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. China
8.6.4.2. Japan
8.6.4.3. India
8.6.4.4. South Korea
8.6.4.5. Taiwan
8.6.4.6. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Medtronic
10.2. Stryker
10.3. Abbott
10.4. B. Braun Melsungen AG
10.5. Boston Scientific Corporation
10.6. Cordis
10.7. Edwards Lifesciences Corporation
10.8. GE Healthcare
10.9. Biosensors International Group, Ltd.
10.10. Biotronik, Inc.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES
Interventional Cardiology Market Report
Trusted by the world's leading organizations
